Avidity Partners Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Avidity Partners Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-520,000	Closed	-$5.24M	–	106
2022 Q4	$5.24M	Hold	520,000	–	–	0.11%	66
2022 Q3	$5.15M	Hold	520,000	–	–	0.1%	76
2022 Q2	$5.09M	Hold	520,000	–	–	0.12%	59
2022 Q1	$5.09M	Hold	520,000	–	–	0.11%	71
2021 Q4	$5.04M	Hold	520,000	–	–	0.11%	76
2021 Q3	$5.07M	Hold	520,000	–	–	0.11%	83
2021 Q2	$5.02M	Buy	+520,000	New	+$5.08M	0.14%	89

Avidity Partners Management's MSAC Position: Q1 2023 in Review

Avidity Partners Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 520,000 shares — an estimated $5.24M sold.

Avidity Partners Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $5.24M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Avidity Partners Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Avidity Partners Management sold 520,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $5.24M.
Avidity Partners Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Avidity Partners Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $5.24M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Avidity Partners Management's 13F filing for Q1 2023, filed 15 May 2023.